Pfizer Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Profit before tax

746.07

824.01

772.89

668.72

642.49

Net cashflow-operating activity

256.84

355.68

667.08

427.33

323.18

Net cash used in investing activity

53.70

-36.05

-575.02

-468.84

1,530.32

Netcash used in fin. activity

-235.14

-345.79

-180.51

-1,571.07

-163.52

Net inc/dec in cash and equivlnt

75.40

-26.16

-88.45

-1,612.58

1,689.98

Cash and equivalnt begin of year

36.60

62.76

151.21

1,763.79

73.81

Cash and equivalnt end of year

112.00

36.60

62.76

151.21

1,763.79